MTOR and hepatocellular carcinoma: TMAO also activated the ILK/AKT/mTOR signaling pathway, which promoted malignant progression for HCC [49], and the TGF-β/SMAD signaling pathway, inducing the development of EMT synergistically with the presence of the heavy metal cadmium (Cd) [50].